envarsus
Showing 1 - 8 of 8
Liver Transplant Rejection, Immune System Suppression Trial (Prograf, Envarsus)
Not yet recruiting
- Liver Transplant Rejection
- Immune System Suppression
- Prograf
- Envarsus
- (no location specified)
Dec 8, 2022
Neurotoxicity, Liver Transplant; Complications Trial in Charleston (Envarsus, Tacrolimus Immediate release)
Active, not recruiting
- Neurotoxicity
- Liver Transplant; Complications
- Envarsus
- Tacrolimus Immediate release
-
Charleston, South CarolinaMedical University of South Carolina
Apr 20, 2022
Renal Transplant Failure Trial in London (Envarsus, Adoport)
Withdrawn
- Renal Transplant Failure
- Envarsus
- Adoport
-
London, United KingdomBarts Health NHS Trust
Mar 21, 2022
Alterations in Cognitive Function and Cerebral Blood Flow After
Completed
- End Stage Renal Disease
- Envarsus
- Tacrolimus
-
Kansas City, KansasUniversity of Kansas Medical Center
Apr 26, 2021
Kidney Transplant; Complications, Toxicity, Drug Toxicity Trial in Sacramento (Envarsus, IR Tacrolimus)
Recruiting
- Kidney Transplant; Complications
- +3 more
- Envarsus
- IR Tacrolimus
-
Sacramento, CaliforniaUC Davis
Jan 25, 2022
Heart Transplant Rejection, Graft Failure, Compliance, Patient Trial in Dallas (Envarsus)
Active, not recruiting
- Heart Transplant Rejection
- +2 more
- Envarsus
-
Dallas, TexasBaylor University Medical Center
Jul 29, 2020
Liver Transplant Rejection, Immunosuppression Trial in Warsaw (Envarsus, Advagraf)
Recruiting
- Liver Transplant Rejection
- Immunosuppression
- Envarsus
- Advagraf
-
Warsaw, PolandWarsaw Medical University
Jul 19, 2018
Kidney Transplant Failure and Rejection Trial (ENVARSUS, Standard twice daily tacrolimus)
Unknown status
- Kidney Transplant Failure and Rejection
- ENVARSUS
- Standard twice daily tacrolimus
- (no location specified)
Dec 28, 2016